91 – 100 of 157
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Distribution and impact on quality of life of the pain modalities assessed by the King's Parkinson's disease pain scale
(
- Contribution to journal › Article
-
Mark
Factors associated with perceived walking difficulties in people with Parkinson’s disease
2017) 21st International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Levodopa effect and motor function in late stage Parkinson’s disease
(
- Contribution to conference › Abstract
-
Mark
The Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale for use in Sweden
2017) 21st International Congress of Parkinson's Disease and Movement Disorders(
- Contribution to conference › Abstract
-
Mark
Etiology and pathogenesis of parkinson’s disease
2017) p.95-101(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2016
-
Mark
Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials.
(
- Contribution to journal › Article
-
Mark
Continuous dopaminergic stimulation therapy for Parkinson's disease - Recent advances
(
- Contribution to journal › Article
-
Mark
A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists
(
- Contribution to journal › Article
-
Mark
Levodopa–Carbidopa Intestinal Gel in Patients with Parkinson’s Disease : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson's disease
(
- Contribution to journal › Article